ghk-cu hair growth topical study Thermodynamically stable ionic liquid microemulsions pioneer pathways for delivery and peptide application GHK-Cu peptide for hair: the

GHK-Cu has not been approved for any therapeutic use in humans by the United States Food and Drug Administration (FDA), nor by any of its international regulatory counterparts

Across the 1980s and 1990s, GHK-Cu was studied extensively in wound healing applications, where it consistently demonstrated the ability to accelerate skin repair, stimulate collagen and glycosaminoglycan synthesis, and reduce inflammation at the site of injury

The GHK-Cu hair growth before and after timeline looks like this: Weeks 1 to 6: Possible mild shedding

Inhibition of these mechanisms by copper efflux results in reduced vascular wall tone, increased myocardial fragility, reduced angiogenesis and ultimately myocardial injury (Fig